As a CEO, my responsibilities extend beyond profit margins and satisfying shareholders. I also find myself reflecting on the impact of my...

Dear colleagues, I wanted to share some additional information regarding the key licensed drugs for Alzheimer's disease. Specifically, I ha

"I am delighted to announce that Viacrystal has been awarded the AA+ certificate, recognizing our creditworthiness and continued...

This article presents the latest status and developments in schizophrenia research, taking into account different medications, new...

Alzheimer's disease is the most common cause of dementia and has received significant attention from researchers in recent decades,...

In the heart of Paris, our company's CEO and Senior Researcher were able to attend the event, where more than 300 researchers exhibited...

Comparative analysis in the field of neurology is used to compare different nervous systems, diseases, and treatment methods. This method...